A
Adrian Covic
Researcher at Grigore T. Popa University of Medicine and Pharmacy
Publications - 605
Citations - 20724
Adrian Covic is an academic researcher from Grigore T. Popa University of Medicine and Pharmacy. The author has contributed to research in topics: Kidney disease & Population. The author has an hindex of 73, co-authored 570 publications receiving 17379 citations. Previous affiliations of Adrian Covic include Romanian Academy & Istanbul Medeniyet University.
Papers
More filters
Journal ArticleDOI
Morning Blood Pressure Surge as a Predictor of Development of Chronic Kidney Disease
Osman Turak,Baris Afsar,Dimitrie Siriopol,Firat Ozcan,Kumral Çağlı,Çağrı Yayla,Fatih Oksuz,Mehmet Ali Mendi,Kazuomi Kario,Adrian Covic,Mehmet Kanbay +10 more
TL;DR: Elevated MBPS is associated with kidney function deterioration and the development of CKD in all models and studies are needed to further examine underlying mechanisms regarding MBPS and these renal outcomes.
Journal ArticleDOI
New molecular insights in diabetic nephropathy.
I A Checheriţă,Gina Manda,Mihai Eugen Hinescu,Ileana Peride,Andrei Niculae,Stefana Catalina Bilha,Angelica Gramaticu,Luminiţa Voroneanu,Adrian Covic +8 more
TL;DR: The review highlights the most significant steps made over the last decades in understanding the molecular basis of diabetic nephropathy (DN), which may provide reliable biomarkers for early diagnosis and prognosis, along with new molecular targets for personalized medicine.
Journal ArticleDOI
Systemic Vasculitis: Still a Challenging Disease
TL;DR: The most recent data on the current management of systemic antineutrophil cytoplasmic antibody-associated vasculitis are reviewed, with emphasis on strategies to improve long-term outcome and reduce treatment toxicity while minimizing the risk for relapse.
Journal ArticleDOI
Treatment of proliferative lupus nephritis--a critical approach.
TL;DR: Recent basic and clinical research has enormously improved the understanding of the pathogenesis of SLE and has suggested new, targeted approaches to therapy, which are expected to help the patients with PLN in the next decade.
Journal ArticleDOI
The role of the renin-angiotensin-aldosterone system in renal artery stenosis, renovascular hypertension, and ischemic nephropathy: diagnostic implications.
TL;DR: The evaluation of the RAAS activity remains an unsolved issue in the clinical assessment of RAS/ischemic nephropathy with important therapeutic consequences, and selection of patients with RAS for revascularization procedures is based on the benefit in terms of renal function improvement/stabilization and improvement of BP control.